EurekAlert! -
1 Dec 2015 07:00
(Federation of American Societies for Experimental Biology) New research published in the Dec. 2015 issue of The FASEB Journal, shows that in mouse models of the disease oral administration of magnesium-L-threonate (MgT) alleviated cognitive decline by suppressing the Aβ deposition in amyloid plaques in an APH-1α/1β-dependent manner.
Share this Article